臨床試驗

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

NCT：NCT04065490 · COMPLETED

NCT IDNCT04065490

狀態COMPLETED

開始日期2019-09-23

完成時間2024-11-01

SponsorLumiThera, Inc. (INDUSTRY)

First posted2019-08-22

Last updated2026-10-08

簡要摘要

This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry AMD. Alcon Research, LLC, acquired LumiThera in September 2025.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。